• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

有机溶质可挽救ΔF508囊性纤维化跨膜传导调节因子的功能缺陷。

Organic solutes rescue the functional defect in delta F508 cystic fibrosis transmembrane conductance regulator.

作者信息

Zhang Xue-Mei, Wang Xi-Tao, Yue Hongwen, Leung Steve W, Thibodeau Patrick H, Thomas Philip J, Guggino Sandra E

机构信息

Department of Medicine, The Johns Hopkins University School of Medicine, Baltimore, Maryland 21205, USA.

出版信息

J Biol Chem. 2003 Dec 19;278(51):51232-42. doi: 10.1074/jbc.M309076200. Epub 2003 Oct 7.

DOI:10.1074/jbc.M309076200
PMID:14532265
Abstract

The most common defect in cystic fibrosis, deletion of phenylalanine from position 508 of the cystic fibrosis transmembrane conductance regulator (Delta F508 CFTR), decreases the trafficking of this protein to the cell surface membrane. Previous studies have shown that low temperature and high concentrations of glycerol or trimethylamine N-oxide can partially counteract the processing defect of Delta F508 CFTR. The present study investigates whether physiologically relevant concentrations of organic solutes, accumulated by cotransporter proteins, can rescue the misprocessing of Delta F508 CFTR. Myoinositol alone or myoinositol, betaine, and taurine given sequentially increased the processing of core-glycosylated, endoplasmic reticulum-arrested Delta F508 CFTR into the fully glycosylated form of CFTR in IB3 cells or NIH 3T3 cells stably expressing Delta F508 CFTR. Pulse-chase experiments using transiently transfected COS7 cells demonstrated that organic solutes also increased the processing of the core-glycosylated form of green fluorescent protein-Delta F508 CFTR. Moreover, the prolonged half-life of the complex-glycosylated form of GFP-Delta F508 CFTR suggests that this treatment stabilized the mature form of the protein. In vitro studies of purified NBD1 stability and aggregation showed that myoinositol stabilized both the Delta F508 and wild type CFTR and inhibited Delta F508 misfolding. Most significantly, treatment of CF bronchial airway cells with these transportable organic solutes restores cAMP-stimulated single channel activity of both CFTR and outwardly rectifying chloride channel in the cell surface membrane and also restores a forskolin-stimulated macroscopic 36Cl- efflux. We conclude that organic solutes can repair CFTR functions by enhancing the processing of Delta F508 CFTR to the plasma membrane by stabilizing the complex-glycosylated form of Delta F508 CFTR.

摘要

囊性纤维化最常见的缺陷是囊性纤维化跨膜传导调节因子(Delta F508 CFTR)第508位的苯丙氨酸缺失,这会减少该蛋白向细胞表面膜的转运。先前的研究表明,低温以及高浓度的甘油或氧化三甲胺可以部分抵消Delta F508 CFTR的加工缺陷。本研究调查了由协同转运蛋白积累的生理相关浓度的有机溶质是否能够挽救Delta F508 CFTR的错误加工。单独的肌醇或依次给予的肌醇、甜菜碱和牛磺酸增加了核心糖基化的、在内质网滞留的Delta F508 CFTR在IB3细胞或稳定表达Delta F508 CFTR的NIH 3T3细胞中加工成完全糖基化形式的CFTR的过程。使用瞬时转染的COS7细胞进行的脉冲追踪实验表明,有机溶质也增加了绿色荧光蛋白-Delta F508 CFTR核心糖基化形式的加工。此外,GFP-Delta F508 CFTR复合糖基化形式的半衰期延长表明这种处理稳定了该蛋白的成熟形式。对纯化的NBD1稳定性和聚集的体外研究表明,肌醇稳定了Delta F508和野生型CFTR,并抑制了Delta F508的错误折叠。最显著的是,用这些可转运的有机溶质处理CF支气管气道细胞可恢复细胞表面膜中CFTR的cAMP刺激的单通道活性以及外向整流氯通道的活性,还可恢复福斯可林刺激的宏观36Cl-外流。我们得出结论,有机溶质可以通过稳定Delta F508 CFTR的复合糖基化形式来增强Delta F508 CFTR向质膜的加工,从而修复CFTR功能。

相似文献

1
Organic solutes rescue the functional defect in delta F508 cystic fibrosis transmembrane conductance regulator.有机溶质可挽救ΔF508囊性纤维化跨膜传导调节因子的功能缺陷。
J Biol Chem. 2003 Dec 19;278(51):51232-42. doi: 10.1074/jbc.M309076200. Epub 2003 Oct 7.
2
Mammalian osmolytes and S-nitrosoglutathione promote Delta F508 cystic fibrosis transmembrane conductance regulator (CFTR) protein maturation and function.哺乳动物渗透溶质和S-亚硝基谷胱甘肽可促进F508缺失型囊性纤维化跨膜传导调节因子(CFTR)蛋白的成熟及功能。
J Biol Chem. 2003 Sep 12;278(37):35159-67. doi: 10.1074/jbc.M301924200. Epub 2003 Jul 1.
3
A novel natural product compound enhances cAMP-regulated chloride conductance of cells expressing CFTR[delta]F508.一种新型天然产物化合物增强了表达CFTR[delta]F508的细胞的环磷酸腺苷(cAMP)调节的氯离子电导。
Mol Med. 2002 Feb;8(2):75-87.
4
Chemical chaperones correct the mutant phenotype of the delta F508 cystic fibrosis transmembrane conductance regulator protein.化学伴侣可纠正ΔF508囊性纤维化跨膜传导调节蛋白的突变表型。
Cell Stress Chaperones. 1996 Jun;1(2):117-25. doi: 10.1379/1466-1268(1996)001<0117:ccctmp>2.3.co;2.
5
Nanomolar affinity small molecule correctors of defective Delta F508-CFTR chloride channel gating.纳摩尔亲和力的小分子校正剂,用于纠正有缺陷的ΔF508-CFTR氯离子通道门控。
J Biol Chem. 2003 Sep 12;278(37):35079-85. doi: 10.1074/jbc.M303098200. Epub 2003 Jun 27.
6
Functional stability of rescued delta F508 cystic fibrosis transmembrane conductance regulator in airway epithelial cells.气道上皮细胞中拯救的 delta F508 囊性纤维化跨膜电导调节剂的功能稳定性。
Am J Respir Cell Mol Biol. 2010 Mar;42(3):363-72. doi: 10.1165/rcmb.2008-0434OC. Epub 2009 Jun 5.
7
In vitro pharmacologic restoration of CFTR-mediated chloride transport with sodium 4-phenylbutyrate in cystic fibrosis epithelial cells containing delta F508-CFTR.在含有ΔF508 - CFTR的囊性纤维化上皮细胞中,用4 - 苯基丁酸钠进行CFTR介导的氯离子转运的体外药理学恢复。
J Clin Invest. 1997 Nov 15;100(10):2457-65. doi: 10.1172/JCI119788.
8
Cystic fibrosis transmembrane conductance regulator trafficking modulates the barrier function of airway epithelial cell monolayers.囊性纤维化跨膜电导调节蛋白转运调节气道上皮细胞单层的屏障功能。
J Physiol. 2010 Apr 15;588(Pt 8):1195-209. doi: 10.1113/jphysiol.2009.182246. Epub 2010 Feb 15.
9
The common variant of cystic fibrosis transmembrane conductance regulator is recognized by hsp70 and degraded in a pre-Golgi nonlysosomal compartment.囊性纤维化跨膜传导调节因子的常见变体被热休克蛋白70识别,并在前高尔基体非溶酶体区室中降解。
Proc Natl Acad Sci U S A. 1993 Oct 15;90(20):9480-4. doi: 10.1073/pnas.90.20.9480.
10
Processing of mutant cystic fibrosis transmembrane conductance regulator is temperature-sensitive.突变型囊性纤维化跨膜传导调节因子的加工过程对温度敏感。
Nature. 1992 Aug 27;358(6389):761-4. doi: 10.1038/358761a0.

引用本文的文献

1
The Use of Small Molecules to Correct Defects in CFTR Folding, Maturation, and Channel Activity.利用小分子纠正囊性纤维化跨膜传导调节因子(CFTR)折叠、成熟及通道活性缺陷
Curr Chem Biol. 2009;3(1):100-111. doi: 10.2174/2212796810903010100.
2
Allosteric folding correction of F508del and rare CFTR mutants by elexacaftor-tezacaftor-ivacaftor (Trikafta) combination.三药复方(Trikafta)依利卓艾他康唑/艾美拉唑/卡博替尼(elexacaftor-tezacaftor-ivacaftor)对 F508del 及罕见 CFTR 突变体的别构折叠校正。
JCI Insight. 2020 Sep 17;5(18):139983. doi: 10.1172/jci.insight.139983.
3
Disorders of FZ-CRD; insights towards FZ-CRD folding and therapeutic landscape.
FZ-CRD 紊乱;对 FZ-CRD 折叠的深入了解和治疗前景。
Mol Med. 2019 Dec 31;26(1):4. doi: 10.1186/s10020-019-0129-7.
4
Unravelling the Regions of Mutant F508del-CFTR More Susceptible to the Action of Four Cystic Fibrosis Correctors.解析突变 F508del-CFTR 更易受四种囊性纤维化校正剂作用的区域。
Int J Mol Sci. 2019 Nov 1;20(21):5463. doi: 10.3390/ijms20215463.
5
Substitution of Yor1p NBD1 residues improves the thermal stability of Human Cystic Fibrosis Transmembrane Conductance Regulator.Yor1p NBD1 结构域残基取代提高了人囊性纤维化跨膜电导调节蛋白的热稳定性。
Protein Eng Des Sel. 2017 Oct 1;30(10):729-741. doi: 10.1093/protein/gzx054.
6
BMP type II receptor as a therapeutic target in pulmonary arterial hypertension.骨形态发生蛋白II型受体作为肺动脉高压的治疗靶点
Cell Mol Life Sci. 2017 Aug;74(16):2979-2995. doi: 10.1007/s00018-017-2510-4. Epub 2017 Apr 26.
7
Non-native Conformers of Cystic Fibrosis Transmembrane Conductance Regulator NBD1 Are Recognized by Hsp27 and Conjugated to SUMO-2 for Degradation.囊性纤维化跨膜传导调节因子NBD1的非天然构象异构体被Hsp27识别并与SUMO-2结合以进行降解。
J Biol Chem. 2016 Jan 22;291(4):2004-2017. doi: 10.1074/jbc.M115.685628. Epub 2015 Dec 1.
8
Assay strategies for identification of therapeutic leads that target protein trafficking.用于鉴定靶向蛋白质转运的治疗先导物的检测策略。
Trends Pharmacol Sci. 2015 Aug;36(8):498-505. doi: 10.1016/j.tips.2015.05.004. Epub 2015 Jun 8.
9
A phenotypic high throughput screening assay for the identification of pharmacoperones for the gonadotropin releasing hormone receptor.一种用于鉴定促性腺激素释放激素受体的药效伴侣分子的表型高通量筛选测定法。
Assay Drug Dev Technol. 2014 May;12(4):238-46. doi: 10.1089/adt.2014.576.
10
Chaperoning G protein-coupled receptors: from cell biology to therapeutics.陪伴G蛋白偶联受体:从细胞生物学到治疗学
Endocr Rev. 2014 Aug;35(4):602-47. doi: 10.1210/er.2013-1121. Epub 2014 Mar 24.